



















The HKCIJ is a leading centre for social justice and human rights. It provides a vibrant 
environment at the cutting edge of legal and criminal justice practice which champions the 
cause of human rights and social justice. The centre is home to a range of social justice and 
human rights activities that include: 
● innovation in teaching and education 
● research and scholarship work 
● international projects 
● impact on policy 
● professional training and advocacy 
 
HKCIJ's central values are widening access to justice and education, promotion of human 
rights, ethics in legal practice, equality and respect for human dignity in overcoming social 
injustice. This report is a part of our commitment to evidencing effective community 
reintegration of marginalised and vulnerable populations, challenging stigma and exclusion, 
and enabling people in recovery to fulfil their potential and be active members of their 
families and communities.  
 
Phoenix Futures provides services, and raises awareness, for people affected by drug and 
alcohol misuse. Since opening its first service in 1969 in London, Phoenix Futures has 
become a registered housing association and supports people affected by drugs and alcohol 
across the UK in prison, community and residential settings. 
  
For more than 45 years Phoenix Futures has worked with individuals, families, and 
communities to show that recovery from substance misuse is possible. Whether struggling 
with substance misuse, supporting a loved one, seeking appropriate housing or employment 
or wanting to build relationships within the community, Phoenix Futures works to ensure 
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Introduction & Overview  
 
Residential treatment services have been a core component of the alcohol and drug 
treatment system in the UK and internationally for a number of years, yet continue to 
provoke debate about their role and their effectiveness, particularly given concerns that they 
are expensive and too disruptive to the lives of people who are trying to reintegrate with their 
families, find employment and establish stable homes.  
 
What we set out to do in this review is to overview the evidence in two areas - first the 
overall evidence, largely from cohort studies, about whether residential treatment services 
are effective. Much of this work comes from (predominantly) drug treatment effectiveness 
studies. We then follow this up with a more detailed analysis of what the evidence base is for 
one particular kind of residential treatment - the Therapeutic Community.  
 
This review is important at this time when funding for alcohol and drug treatment is under 
great pressure. Service users, providers and commissioners all share a desire and need for 
a clear evidence base in order to allocate critical and limited resources effectively and 
efficiently. This review is intended to increase stakeholders' and interested persons' 
knowledge and understanding of the operation of this sector of alcohol and drug treatment 
services and guide decisions towards enhancing and improving outcomes. 
 
The parameters for the initial evidence search aimed to find national level adult cohort 
studies that investigated whether residential treatment for alcohol addiction was more or less 
effective than community treatment. Therefore the primary search interest was concerned 
with studies that address research question one (RQ1), whether residential treatment 
improved an individual's treatment outcomes across a range of measures - not only alcohol 
and drug use but also offending and criminal justice involvement, employment, housing and 
quality of life. 
 
The key secondary research questions that we wished to address were:  
 RQ2: Is there an optimal or minimum duration of time for residential treatment to be 
effective? 




 RQ4: What are the key components of preparation, continuity of care and aftercare that 
may predict who does well in residential treatment?  
 
For the initial section, around treatment effectiveness, the aim was to look at national and 
international research that used naturalistic methods with cohorts of treatment seekers to 
assess the evidence for: 
(a) is residential treatment effective? 





Summary of key conclusions 
 Overall, it is clear that an effective and recovery-oriented treatment system must include 
ready access to residential treatment for alcohol and drug users both to manage the 
needs of more complex populations and for those who are committed to an abstinence-
based recovery journey 
 
 There is a strong and consistent evidence base supportive of the benefits of residential 
treatment that derives both from treatment outcome studies and randomised trials 
 The areas of benefit focus primarily on reductions in substance use and offending 
behaviour but some studies also show benefits in areas including physical and mental 
health, housing stability and employment  
 Although more expensive, there is evidence that the initial costs of residential treatment 
are to a large extent offset by reductions in subsequent healthcare and criminal justice 
costs  
 There is a clear dose effect for residential treatment with longer duration of treatment 
and treatment completion both strong predictors of better outcomes  
 Although there have been arguments (particularly in the UK) for minimum effective 
doses of 28-days for detoxification and 90-days for residential treatment, the evidence 
would suggest a cumulative benefit of longer times in treatment  
 In some studies, particularly from Australia, there is a strong longevity of added value 
for residential treatment with differences still apparent in the ATOS project at the 11-
year outcome point  
 There is a limited evidence base about who does better in residential treatment 
although there is some evidence that those who are older and who have less forensic 
and psychiatric histories will have better outcomes  
 There is a strong supportive evidence base around continuity of care, whether this 
takes the form of recovery housing or ongoing involvement in mutual aid groups 
 There is almost no evidence for appropriate selection and preparation of clients for 
residential treatment and this is a major gap in the literature  
 A much stronger evidence base exists around attaining employment, stable housing, 





Section 1: Evidence for residential treatment from treatment outcome studies 
In the UK, there have been major treatment outcome studies conducted in England, 
Scotland and Ireland and each of these will be briefly reviewed. Then studies that have been 
conducted in Australia and the US will be reviewed. 
 
1.1 England  
a. The National Treatment Outcome Research Study (NTORS) (Initiated in 1995). 
Authors: Gossop, M., Stewart, D. & Marsden, J. (2000). 
 
The aim of the National Treatment Outcome Research Study (NTORS) was to recruit a 
cohort of drug users at the initiation of a range of types of specialist drug treatment. The 
study was a prospective five-year cohort multi-site study investigating four drug treatment 
modalities (in-patient detoxification (n=8), residential rehabilitation (n=15), methadone 
reduction and methadone maintenance) across 4 time-points (baseline, 1 year, 2 years, 4-5 
years). Participants at the baseline assessment comprised 1075 treatment seekers recruited 
from 54 residential and community agencies. Participants recruited from 23 residential 
treatment programmes were 408 problem opiate users. 
 
Results at the 1 year follow-up for residential patients showed statistically significant 
reductions in all drug related behaviour; rates of abstinence for all drugs had increased with 
one third of participants from residential treatment programmes abstinent from all target 
drugs over the previous 3 months. Less than one fifth of participants were exceeding 
recommended levels for alcohol use. Levels of criminal activity had approximately halved 
(see Gossop, Marsden, Stewart, Duncan, & Rolfe, 1999). At the two year follow-up point, 
33% of participants (n=192) from the residential units were abstinent from all six illicit target 
drugs in the last 3 months. Psychological and physical health problems were also 
significantly lowered. At the 5 years' follow-up, 38% of participants from residential 
programmes were abstinent from all six illicit target drugs. Sharing of injecting equipment fell 
(non-significant) from 2-year follow-up, and there were significantly fewer psychological 
problems recorded between 4-5 years and intake. Levels of criminal activity (acquisitive and 
drug-selling) were significantly lower than at intake. 
 
Better post-treatment outcomes (abstinence from opiates and alcohol) were observed 




comparison to non-attenders and infrequent attenders (less than one week) (Gossop 
et al., 2003), supporting the need for continuity of care and support for this 
population. 
 
There was a clear benefit from residential treatment programmes for female residents in the 
area of psychological health. 
 
Logistic regressions showed that there were critical minimum durations of stay of 28 
days for in-patient detoxification and short term rehabilitation and 90 days for longer 
term rehabilitation services (see Gossop et al., 1999). 
 
These critical periods were related to the likelihood of improvement in overall drug use and 
abstinent rates (all target drugs), which were five times higher at follow-up. Numbers of 
clients who stayed for critical times were: inpatient programmes, 20% (28 days); short stay 
rehabilitation, 64% (28 days); longer-stay rehabilitation, 40% (90 days). Gossop, Stewart, 
Browne and Marsden (2002) in assessing the predictors of relapse in the residential sub-
group of the NTORS reported that treatment completion in both detoxification and 
rehabilitation services was predictive of positive outcomes as was higher levels of coping 
skills.  
 
Overall recommendations: Treatment time and retention is predictive of positive post-
treatment outcomes. Residential rehabilitation programmes are especially suited to 
patients with more complex needs for whom greater benefits are observed. Provision 
of treatment facilities (length of stay and quantity of provision) should be driven by clinical 
considerations and not by short-term cost cutting exercise of outside providers for short-term 
gain. It was suggested that allocation of sparse resources needs careful consideration to 
achieve these outcomes. 
 
Additionally, in a follow-up paper that focused specifically on cost-benefit analysis of the 
NTORS sample, Healey et al. (2003) concluded that increasing expenditure on treatment 
services for heroin addicts can reduce their offending behaviour, and also shows the 
differentiation between residential and non-residential services in the amounts saved, 




was clear in suggesting that while all treatment was beneficial to the public purse the 
greatest economic benefit was conferred by residential treatment.  
 
b. The Drug Treatment Outcome Research Study (DTORS, 2006-2007). Authors: 
Donmall, M., A. Jones, Davies, L. and Barnard, M. (2009). 
 
The Drug Treatment Outcome Research Study (DTORS) was commissioned by the Home 
Office and carried out at Manchester University (2007). The aim was to measure and update 
the overall outcomes of those seeking drug treatment within England, with a particular 
emphasis upon treatment outcomes, treatment-related issues and including a cost-benefits 
analysis. Although sample retention for the follow-up component of the study was poor, there 
were general improvements reported across all of the treatment modalities included. 
Nonetheless, controlling for baseline factors, those who had received residential 
rehabilitation (regardless of current situation), CJS referrals, and primary users of 
drugs other than heroin recorded better health outcomes at all time-points of the 
study.  
 
Supplementing these outcome studies, Gossop and Strang (2000) reviewed the evidence for 
the cost effectiveness of residential treatment. The authors found that the costs of the 
services are markedly different, with the weekly costs of inpatient detoxification 24 times 
more than outpatient detoxification. When adjustments are made for outcome, the gap 
narrows. A lengthier stay on an inpatient unit was over 3 times more expensive than a brief 
admission to a general psychiatric ward. Additionally, the characteristics and inherent 
problems of drug users who use each of the services are very different. In general, more 
difficult cases are dealt with by residential programmes and are important factors to consider 
when analysing cost.   
 
1.2 Ireland 
Research Outcomes Study in Ireland evaluating Drug Treatment Effectiveness 
(ROSIE) (Initiated in 2003). Authors: Comiskey, C.M., Kelly, P., Leckey, Y., McCulloch, L., 
O'Duill, B., Stapleton, R.D. & White, E. (2009). 
 
The Research Outcomes Study in Ireland evaluating Drug Treatment Effectiveness (ROSIE) 




aim was to provide the first prospective longitudinal outcome study of effectiveness of 
treatment and other options for opiate users. 404 opiate users were recruited from 54 
services provided by 44 separate agencies/organisations. 
 
Significant reductions in drug use at the one-year point were sustained to the three-year 
follow-up, particularly around substance use, offending and injecting, but the picture was 
more mixed around physical and psychological health. However, it was difficult to factor out 
the impact of residential treatment as it contained both detoxification and rehabilitation 
services and the 'abstinence' group also contained a small number of patients treated in the 
community.  
 
1.3 Scotland  
The Drug Outcome Research in Scotland (DORIS) (Initiated in 2001). Authors: 
McKeganey, N., Bloor, M., Robertson, M., Neale, J., & Macdougall, J. (2006). 
 
The Drug Outcome Research in Scotland study (DORIS) was funded by the Robertson Trust 
with additional support from the Scottish Government and Health Protection Scotland. 
Implementation was by the Centre for Drug Misuse Research, University of Glasgow. DORIS 
was designed to deliver evidence regarding the effectiveness of drug treatment modalities 
within the country. The project was a multi-site cohort study investigating a range of drug 
treatment modalities (substitute prescribing, non-substitute prescribing, counselling, 
residential rehabilitation, detoxification, needle-exchange) followed up across 4 time-points 
(baseline, 8 months, 16 months and 33 months after the baseline interview). 
 
Among the key findings of the study were that at the 33-month follow-up point, 
participants recruited from residential rehabilitation programme had greater levels of 
abstinence from non-prescription drug use (24.7%) than those from a community-
based drug treatment agency (6.4%) and a prison-based drug treatment agency 
(4.9%). There were strong association between residential rehabilitation treatment 
engagement and abstinence and, for the majority of participants interviewed (76%), the main 
aim of treatment (56%) was abstinence. In a comparison between abstinent and non-
abstinent participants from DORIS, abstinence was associated with significantly higher 33-
month reductions in levels of arrest, crime, suicide/self-harm, alcohol misuse, and with 




2006). The authors concluded that there was an imbalance of services where the most 
effective route for abstinence was residential rehabilitation and yet where minimal provision 
was offered, with only 2% of project participants being offered this form of treatment. 
 
1.4 Australia 
a. The Australian Treatment Outcomes Study-Heroin (ATOS) (2002-2013). Authors: 
Teesson, M., Ross, J., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006). 
 
The study aimed to investigate the population of individuals seeking treatment for problems 
linked with heroin use who received treatment and to develop treatment outcomes in the 
Australian context. The study was conducted in collaboration with National Drug and Alcohol 
Research Centre in New South Wales, Turning Point Alcohol and Drug Centre in Victoria 
and the Drug and Alcohol Services Council in Southern Australia. 
 
Reduction in heroin use was observed at 3- to 12- to 24- to 36-month follow-up assessments 
and remained stable. At all follow-ups, reduction in use of other drugs was observed at 3- to 
12- to 24-months, and then remained stable to 36-months. The number of treatment 
episodes was not linked to this reduction. Reductions in criminal activity were observed 
between 3- to 12- to 24-months, and then remained stable to 36-months. Poorer outcome 
was linked to fewer treatment episodes, youthful age and presence of major depression. 
Physical health improved from 3- to 12-months, remained stable to 24-months, and then 
deteriorated to 36-months. 
 
More time spent in residential rehabilitation was associated with a greater reduction 
in heroin dependency and more abstinence from heroin. More time spent in residential 
treatment was also associated with reductions in other drug use, needle sharing, and 
criminal activity. Overall improvement in physical health was related to residential 
rehabilitation to a greater extent than involvement in other forms of treatment.  
 
A further analyses of recipients of residential clients (n=100) from the NSW component of 
the ATOS study was conducted at 3 years follow-up (Teesson et al., 2008), which showed 
that the reduction in heroin use evidenced at 12-month follow-up was still present. Twenty-
five percent of residential clients reported one year of heroin abstinence from index 




to have achieved this status. These participants were nine times more likely to have 
completed their index treatment programme. Most significantly, analyses demonstrated 
that successful completion and graduation from the residential treatment programme 
was linked with greatly enhanced outcomes. Successful completion and graduation 
was of greater importance for sustained abstinence than programme type or length. 
 
An 11-year follow-up was conducted by Teesson et al. (2015) in which the authors 
successfully engaged 431 participants (70.1%) from the original sample. At the 11-year 
follow-up, 24.8% were still using heroin, and almost half were still in current treatment. 
Where heroin had reduced or stopped, there were significant improvements across a range 
of life domains. Current heroin abstinence was more likely in the group who had engaged in 
residential rehabilitation at baseline (OR=1.68), while residential rehabilitation treatment at 
baseline was also associated with lower likelihood of needle sharing at the 11-year follow-
up. Criminality at the 11-year follow-up was higher among those whose baseline treatment 
had been detoxification and lower among those whose baseline treatment had been 
residential rehabilitation. At some point in the 11 years, 54.2% of the sample had accessed 
residential rehabilitation treatment. As such, the long-term outcomes from the ATOS 
study provide a strong endorsement of residential treatment and the longevity of its 
positive effects. 
 
b. The Methamphetamine Treatment Evaluation Study (MATES) (2006-2008). Authors: 
Mcketin, R., Najman, J. M., Baker, A. L., Lubman, D. I., Dawe, S., Ali, R., Lee, N.K., Mattick, 
R.P. & Mamun, A. (2012). 
  
The study was the first Australian longitudinal cohort outcome study to evaluate community-
based treatment for methamphetamine and derive treatment effects. The study was 
conducted by the Centre for Mental Health Research, Australian National University, 
Canberra.  
 
Participants were recruited on entry from 11 randomly selected detoxification units (n=112) 
and 15 residential rehabilitation facilities (n=248) in Sydney and Brisbane. Overall, the study 
findings showed positive benefits of treatment for methamphetamine users with particularly 
strong effects in the residential rehabilitation group. There was a significant increase in 




rehabilitation when compared with the quasi-control and detoxification groups, although this 
effect reduced with time. 
 
c. Australian Study of Patient Pathways in Alcohol and Other Drug Treatment (2012-
2013). Authors: Manning, V., Garfield, J. B., Best, D., Berends, L., Room, R., Mugavin, J., 
Larner, A., Lam, T., Buykx, P., Allsop, S. & Lubman, D. I. (2016). 
 
Patient treatment experiences have typically been measured through outcome studies 
investigating individual substance use, with the primary focus upon the individual treatment 
journey. As such, they have neglected the complexity of the pathways that have led to 
improvement in overall health, greater social capital and reduction in acute healthcare costs. 
This study attempted to map the pathways of specialist and linked services that clients utilize 
to navigate their route to healthier outcomes for a combination of alcohol and drug users. 
796 clients (62% male) were recruited to the study on entry to their primary index treatment 
(PIT); 29% from long-term residential treatment, 44% from acute withdrawal services, and 
27% from a range of other outpatient services.  
 
Outcomes were recorded from baseline and 12 month follow-up (n=555) interviews. Reliable 
change criteria (RCC) (Jacobson & Truax, 1991) demonstrated significant reduction from 
baseline to follow-up in primary drug of concern (PDOC) for over half of participants. Over 
thirty percent of participants were abstinent one month prior to 12-month follow-up. Sixty-six 
percent reported completion of PIT with 6% remaining in their PIT for the study duration. 
Significant predictors of treatment success were completion of PIT and attendance at 
mutual aid. For clients with alcohol as their PDOC, abstinence was predicted by 
residential rehabilitation and mutual aid attendance. For client with drugs as their 
PDOC, completion of PIT was more relevant than either residential rehabilitation or 
mutual aid attendance. Overall, positive health outcomes were linked with a period of 
residential rehabilitation and continuity into specialist AOD treatment, with completion of PIT 
the most significant predictor of treatment success. 
 
Residential rehabilitation was significantly implicated in positive health outcomes, 
especially for those with alcohol as their PDOC in the Australian Patient Pathways 
study. The authors concluded that greater access to residential rehabilitation would benefit 




d. Retention, early dropout and treatment completion among the therapeutic 
community admissions. Authors: Darke, S., Campbell, G. and Popple, G. (2012). 
 
This study aimed to examine the correlations between treatment retention and completion, 
drop-out rates and baseline client characteristics. Based in a single service in Sydney, the 
median length of stay was 39 days, 64 days for men and 32 days for women. A total of 17% 
left treatment in the first week, 25% between 2 and 4 weeks, 13% between 5 and 8 weeks, 
and 18% between 9 and 12 weeks; 27% remained in treatment for more than 12 weeks. A 
total of 41% of participants left treatment against advice (men 40%, women 45%). A 
significant correlation was observed between length of stay and previous TC 
completion, better physical health scores and lower number of stressful life events. A 
gender difference was noticeable, with 2 in 5 men completing compared to 1 in 5 women. 
 
1.5 USA 
a. The Drug Abuse Reporting Programme (DARP) (1968-1980). Authors: Simpson, D. D. 
& Sells, S. B. (1982).  
 
The aim of the study was to evaluate and monitor the federal addiction treatment system 
within the United States and Puerto Rico. The study also created a database for treatment 
evaluation research. The study was implemented by the Institute of Behavioural Research 
(IBR), Texas Christian University. 
 
DARP was a prospective, longitudinal study of four treatment modalities: methadone 
maintenance (MM), residential therapeutic communities (TC), outpatient drug-free (DF) and 
outpatient detoxification (DT). Additionally, there was a comparison group labelled intake-
only (IO) for those who sought but never accessed treatment. Follow-up interviews ranged 
from 3 months to 12 years after treatment initiation. 
 
Results for TCs consistently demonstrated ‘highly favourable’ and ‘favourable’ post 
treatment outcomes, compared to DT and IO groups. Levels of criminal activity 
dropped significantly for TC and were ‘highly favourable’. Levels of employment 
increased and were ‘highly favourable’. ‘Highly favourable’ outcomes were achieved 




study was a strong endorsement of duration of treatment with longer retention across 
modalities being associated with better outcomes.  
 
b. Treatment Outcome Prospective Study (TOPS) (1979-1986). Authors: Hubbard, R. L., 
Rachal, J. V., Craddock, S. G., & Cavanaugh, E. R. (1984).  
 
The aim of the TOPS project was to replicate DARP to assess the outcomes of short and 
long-term drug treatment options within the US. Length of time in treatment was a significant 
predictor for behavioural change with longer periods necessary for any positive outcomes to 
occur, which meant typically more than 12-months. Heroin use reduced in the methadone 
maintenance and residential rehabilitation groups only. There were noted differences in 
the quality of treatment offered to clients of residential rehabilitation as the study 
progressed with ‘noticeably’ less services being offered (family, educational and 
vocational services). This is further opportunistic evidence that rehabilitation services 
need appropriate duration and resourcing to maximise treatment gains.  
 
c. The Drug Abuse Treatment Outcome Study (DATOS) (Initiated in 1989). Authors: 
Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997). 
 
This was a prospective, longitudinal outcomes study from multiple selected sites (n=96) in 
eleven cities. Four treatment modalities were included - outpatient methadone (OM), 
outpatient drug-free (ODF), long-term residential (LTR) and short-term inpatient (STI). In the 
12-months follow-up interview, the only significant finding between groups was that 
participants who spent 90 days or more in long-term residential treatment had the most 
significant reductions in drug-use (cocaine, marijuana, alcohol), along with significant 
reductions in criminal activity and significant increases in rates of employment. A key 
finding from this study revealed that the most positive outcomes over 4 treatment 
modalities were linked with long-term residential treatment when the duration of stay 






There are a number of preliminary conclusions that can be made on the basis of the review 
of treatment outcome studies that are summarised here and discussed in greater length at 
the end of the review: 
 
1. There is little evidence for detoxification as an evidence-based standalone treatment 
 
2. There is often poor access to residential treatment, particularly rehabilitation, in the UK 
and internationally in spite of a strong supportive evidence base 
 
3. There are good outcomes for residential treatment, but these are generally linked to 
longer retention in treatment and treatment completion  
 
4. There is some evidence in the UK for minimum periods of stay for both residential 
treatment (90 days) and in-patient detoxification (28 days) to maximise effectiveness; and a 
very clear international evidence base supporting continuity of care following completion of 
residential treatment 
 
5. Residential rehabilitation services are generally dealing with a complex client group with 
multiple disadvantages, yet generally achieve equivalent or better results to other modalities 
of treatment 
 
6. Completion rates for residential treatment are typically low but retention linked to 
outcomes and positive outcomes are also linked to continuity of care 
 
7. Staff quality and treatment resourcing has also been associated with more positive 
treatment outcomes in the US (TOPS) 
 
8. Budget cuts have adversely affected the integrity and availability of this key resource and 
may lead to sub-optimal delivery 
 
9. There is limited evidence about targeted populations with better outcomes associated with 
those with less criminal justice involvement who achieve employment after residential 




10. There is almost no evidence around preparation for treatment or selection of residents 




Section 2: Evidence for the benefits of Therapeutic Communities 
There have been inconsistent findings from systematic reviews of the evidence around the 
effectiveness of Therapeutic Communities (TC) that have been based on methodological 
differences. Thus, the Cochrane Review conducted by Smith, Gates and Foxcroft in 2008 
concluded that there was little evidence that TCs conferred additional benefit over other 
forms of residential treatment, or that one type of TC is better than another in terms of either 
treatment outcomes or retention. However, this review was based on only seven randomised 
controlled trials and there were both significant methodological weaknesses and 
inconsistencies between the studies included in the review. Further, as Vanderplasschen et 
al. concluded in their review for the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA), randomised trials may not be the most appropriate study design for an 
intervention such as a TC which requires significant personal commitment to a holistic model 
of care.  
 
Earlier, Lees, Manning and Rawlings (2004) had conducted a systematic review of TCs 
based on 29 studies of which 8 were randomised trials. Using a single global measure of 
successful outcome, the authors concluded that there was a strong positive effect for TC 
treatment compared to a range of control interventions. In a subsequent systematic review, 
De Leon (2010) included four different categories of studies - field effectiveness studies, 
randomised trials, meta-analyses and cost benefit studies - and concluded that there was 
consistent evidence of positive effects of TCs across all four categories of research study. 
De Leon concluded that all five cost-benefit analyses have shown positive findings in favour 
of TCs, in particular associated with reduced involvement in criminal justice and increased 
involvement in employment. De Leon also argued that there is a clear relationship between 
both treatment completion and treatment outcome, and between duration of stay and 
positive outcomes.  
 
The focus on retention was picked up by Malivert, Fatseas, Denis, Langlois and Auriacombe 




treatment following other forms of treatment. In keeping with previous studies, one of the 
prime concerns was the variable and low rates of treatment completion (between 9% and 
56% in the included studies) - however, the authors concluded that the most robust 
predictors of abstinence at follow-up were treatment completion and duration of stay 
in the TC treatment facility.  
 
In their subsequent review of the evidence for the EMCDDA, Vanderplasschen, Vandevelde 
and Broeckaert (2014) included both controlled studies internationally (30 publications) and 
field effectiveness studies undertaken in Europe (20 publications). The 30 trial publications 
covered 13 studies with analysis indicating that 10 of 14 showed better substance use 
outcomes among the TC group and 9 of 13 showed at least one better legal (criminal justice) 
outcome for the TC group. Crucially, Vanderplasschen and colleagues also assessed 
predictors of relapse and recidivism and concluded that participation in aftercare, 
post-treatment employment and older age were the strongest predictors of effective 
desistance and abstinence. These findings were largely consistent with the findings from 
the field effectiveness studies in Europe, with a particularly clear relationship reported 
between longer duration of stay and better treatment outcomes.  
 
Vanderplasschen and colleagues concluded that the most obvious benefits of TC treatment 
are lower rates of recidivism and lower rates of relapse (found in more than half of all of the 
studies included) in spite of significant differences in study design and participant 
characteristics within each study. The authors conclude that treatment in TCs takes time - 
typically 6 to 12 months - and that as a result is probably only suited for those substance 
users whose needs cannot be met in less intensive forms of treatment. However, 
Vanderpasschen and colleagues concluded on a cautious note, stating that "because of the 
variance in client profiles it is yet to be established who benefits from TC treatment (and at 
what point in the recovery process)" (p.56).  
 
More positively, in a subsequent peer-reviewed paper based on the above review, 
Vanderplasschen et al. (2013) concluded that "Despite various methodological constraints, 
TCs appeared to generate significantly better outcomes in comparison with other viable 
interventions in two out of three studies. … If residents stay long enough in treatment and 





Section 3: Additional UK evidence 
In a specific study focusing on factors that predicted completion of residential treatment in 
the UK, Meier and Best (2006) found that residential treatment services in the UK had 
markedly varying retention rates for 90 days of treatment, ranging from 25% to 48%. The 
aim of the paper was to identify programme level factors associated with retention and these 
were primarily related to (1) privacy of the client, (2) higher staff/client ratio and domestic 
services support and (3) individual counselling, with higher levels linked with greater 
retention of clients. Additionally, greater programme intensity and higher numbers of beds 
per facility were both associated with lower retention rates to 90 days.  
 
In a follow-up study, Meier and colleagues (2006) recruited 187 residents from two 12-step 
based residential services and one TC, reporting that 53% achieved 90 days of treatment 
retention but that 28.7% had left within the first two weeks of treatment. Older individuals 
with more educational exposure were more likely to complete. Pre-treatment crack use, 
secure attachment style and developed coping strategies were linked with shorter retention. 
The author concluded that counsellors who were experienced were more able to retain 
clients who are more able to engage with a therapeutic relationship (i.e., older and 
higher levels of education). 
 
Another UK study that looked specifically at the impact of aftercare and continuity of care 
following residential treatment was carried out in London by Gossop et al. (2003) in a study 
designed to investigate the influence of the mutual aid fellowship group of Alcoholics 
Anonymous prior to, during and after in-patient treatment within a specialist South London 
NHS unit for alcohol problems. Significant associations were recorded for participants 
(15%) between frequency of post-treatment AA attendance and reduction in drinking 
behaviour. AA attendance was not significantly associated with reduction in psychiatric 
symptoms or quality of life at 6-months follow-up, suggesting the importance of both mutual 
aid and continuity of support in the community following residential treatment.  
 
Along similar lines, Manning et al. (2012) conducted a randomized control trial comparing 
two active referral interventions - 12-Step peer referral (PI) and doctor referral (DI) - with a 
standard/no intervention (NI) to ascertain the effectiveness of linkage to 12-Step mutual aid 
groups (Alcoholics Anonymous, Narcotics Anonymous, Cocaine Anonymous) with 




patients attending short-term residential treatment. Assertive linkage to 12-Step mutual 
aid groups resulted in positive outcomes, with intervention groups attending more 
frequently post-discharge. Abstinence was significantly linked with more frequent 
attendees of 12-Step groups. The importance of peer support and assertive linkage 




Section 4: Additional international evidence  
4.1 Australia: Predicting dropout in the first 3 months of 12-step residential drug 
and alcohol treatment in an Australian sample. Authors: Deane, Wootton, Hsu and Kelly 
(2012). 
 
Deane and colleagues collected data from eight residential drug and alcohol treatment 
programs run by The Australian Salvation Army, based on a sample of 618 participants. 
Individuals were more likely to drop out by the 3-month time frame if at intake their primary 
drug of concern was a drug other than alcohol or they reported greater forgiveness of self. 
 
4.2 Thailand: Evaluation of a Therapeutic Community Treatment Model. Authors: 
Johnson, Young, Shamblen, Suresh, Browne and Chookhare (2012). 
 
The study, conducted in 2005 to 2007, used a proscriptive cohort design, based on 769 
residents in 22 treatment programs. The results show large positive treatment effects on 30-
day and 6-month illegal drug use and small to medium effects on the severity of alcohol use 
and related problems. Reduced stigma, adaptation of the TC model, and frequency of 
alcohol and drug use-related consequences partially predict treatment success.  
 
4.3 New Zealand: Predictors of 3-month retention in a drug treatment therapeutic 
community. Authors: Mulder, Frampton, Peka, Hampton and Marsters (2009). 
 
This study examined rates of 3-month retention in a drug treatment therapeutic community 
and the characteristics of residents who remain in treatment, based on 187 consecutive 
admissions. 107 remained in the program for at least 3 months. These residents had a better 




lifetime stimulant dependence, with differences predicting around 18% of the variance in 
outcome.  
 
4.4 USA: a. Evaluating Alternative Aftercare Models for Ex-Offenders. Authors: 
Jason, Olson and Harvey (2015). 
 
This study examined the role played by aftercare following (mainly) inpatient community-
based treatment in the outcomes of criminal ex-offenders with substance use disorders. Two 
hundred and seventy individuals released from the criminal justice system were randomly 
assigned to either therapeutic communities (TC), recovery homes called Oxford Houses 
(OHs), or usual care settings (UA). The OHs and TCs are residential settings that 
emphasized socialization and abstinence from drugs and alcohol, but OHs do not include the 
formal therapeutic change interventions common to TCs, nor do they include any on-site 
access to drug abuse or health care professionals. UA involved what occurred naturally after 
completing treatment, which included staying with friends or family members, their own 
house or apartment, homeless shelters, or other settings. Longer lengths of stay in either the 
TCs or OHs were associated with increased employment, and reduced alcohol and drug 
use. Those assigned to the OH condition received more money from employment, worked 
more days, achieved higher continuous alcohol sobriety rates, and had more favourable 
cost-benefit ratios. This study provides further evidence of the importance of continuity 
of care and the importance of a protective and stable home environment that can 
encourage and nurture recovery pathways.  
 
b. A randomized trial comparing day and residential drug abuse treatment: 18-month 
outcomes. Authors: Guydish, Sorensen, Chan, Werdegar, Bostrom and Acampora (1999). 
 
Extending an earlier report of 6-month outcomes, this study reports 12- and 18-month follow-
up data for clients (n=188) entering a therapeutic community drug treatment program who 
were randomly assigned to day or residential treatment conditions. Both groups showed 
significant change over time. The pattern of change indicated decreased problem severity in 
the first 6 months and then maintenance of lowered problem severity. Comparisons between 
groups indicated greater improvement for residential treatment clients on social problems 





c. Outcomes at 1 and 5 years for older patients with alcohol use disorders. Authors: 
Lemke and Moos (2003). 
 
Older patients with alcohol use disorders who had gone through residential treatment were 
compared with matched groups of young and middle-aged patients (n=432 in each age 
group) on their 1- and 5-year outcomes, use of continuing care services, and outcome 
predictors. Older patients had better outcomes than did young and middle-aged patients but 
had comparable levels of continuing substance abuse care and 12-step self-help group 
involvement. Longer duration of continuing substance abuse care and greater self-help 
group involvement were related to better outcomes, as were patients' attitudes and coping 






Section 5: Conclusions 
 
5.1 Key overall conclusion 
 Overall, it is clear that an effective and recovery-oriented treatment system must include 
ready access to residential treatment for alcohol and drug users both to manage the 
needs of more complex populations and for those who are committed to an abstinence-
based recovery journey 
 
5.2 Key conclusions by related research question 
 
RQ1: Does residential treatment improve an individual's treatment outcomes across a 
range of measures, to include not only alcohol and drug use but also offending and 
criminal justice involvement, employment, housing and quality of life? 
 There is a strong and consistent evidence base supportive of the benefits of residential 
treatment that derives both from treatment outcome studies and randomised trials 
 The areas of benefit focus primarily on reductions in substance use and offending 
behaviour but some studies also show benefits in areas including physical and mental 
health, housing stability and employment  
 Although more expensive, there is evidence that the initial costs of residential treatment 
are to a large extent offset by reductions in subsequent healthcare and criminal justice 
costs  
 
RQ2: Is there an optimal or minimum duration of time for residential treatment to be 
effective? 
 There is a clear dose effect for residential treatment with longer duration of treatment 
and treatment completion both strong predictors of better outcomes  
 Although there have been arguments (particularly in the UK) for minimum effective 
doses of 28-days for detoxification and 90-days for residential treatment, the evidence 
would suggest a cumulative benefit of longer times in treatment  
 In some studies, particularly from Australia, there is a strong longevity of added value 
for residential treatment with differences still apparent in the ATOS project at the 11-





RQ3: Is residential treatment more or less effective with different populations? 
 There is a limited evidence base about who does better in residential treatment 
although there is some evidence that those who are older and who have less forensic 
and psychiatric histories will have better outcomes  
 
RQ4: What are the key components of preparation, continuity of care and aftercare 
that may predict who does well in residential treatment? 
 There is a strong supportive evidence base around continuity of care, whether this 
takes the form of recovery housing or ongoing involvement in mutual aid groups 
 There is almost no evidence for appropriate selection and preparation of clients for 
residential treatment and this is a major gap in the literature  
 A much stronger evidence base exists around attaining employment, stable housing, 
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